Revolution Medicines says its potential breakthrough pancreatic cancer drug succeeds in late-stage trial

https://www.cnbc.com/2026/04/13/pancreatic-cancer-drug-daraxonrasib-from-revolution-medicines-succeeds-in-trial.html?link_source=ta_bluesky_link&taid=69dcdc193ac5f60001f3230f